Now a Virtual Experience: 2020 ISPE Continuous Manufacturing Virtual Workshop 

A New Decade for Continuous Manufacturing: Current Landscape & Future Opportunities 

We continue to monitor the unfolding global impact of COVID-19, and as the world evolves, so do we. We are transforming this event to be fully digital: The 2020 ISPE Continuous Manufacturing Virtual Workshop.

You will still: 

  • Explore two tracks on continuous manufacturing for large molecules – drug substance, and continuous manufacturing for small molecules – drug product, drug substance, and API 
  • Identify the supply chain, safety, and quality assurance advantages provided by continuous manufacturing 
  • Learn about the different approaches to continuous manufacturing regarding equipment, measurement tools, and control strategies 
  • Analyze avenues for enhanced communication with regulators on innovative and emerging technologies 

It's our priority to make this the best and most informative 2020 ISPE Continuous Manufacturing Virtual Workshop to date, and we remain excited to host you in June. We will update the event page in the coming weeks with additional information.

Who Should Attend?

Engineers Engineering Managers & Directors OperationsProcess Engineers PAT SpecialistsValidation SpecialistsRegulatorsPlant Directors & ManagersProject Managers

Program Committee

Christine M. V. Moore, PhD
Global Head and Executive Director, GRACS CMC Policy
Merck & Co.
Chair and Board Ambassador
Gabriella Dahlgren, PhD
Manager, Strategy Deployment and Excellence, PQM
Janssen Supply Group LLC
Kelvin H. Lee, PhD
Prof. of Chemical & Biomolecular Engineering, Univ. of Delaware, & Director
Michael K. O'Brien, PhD
Founder & President
NGT BioPharma Consultants
Jeffery N. Odum, CPIP
Head of Design, Technology & Standards, Biologics Engineering
Antonio R. Moreira, PhD
Vice Provost, Academic Affairs
University of Maryland, Baltimore County
Malcolm B. Berry
Continuous Chemistry Team Manager
Wyatt J. Roth, PhD
Senior Research Scientist
Eli Lilly & Co.